# Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler

> **NCT05459194** · NA · COMPLETED · sponsor: **Elpen Pharmaceutical Co. Inc.** · enrollment: 42 (actual)

## Conditions studied

- Asthma

## Interventions

- **DEVICE:** RP - TA

## Key facts

- **NCT ID:** NCT05459194
- **Lead sponsor:** Elpen Pharmaceutical Co. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2022-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05459194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05459194, "Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05459194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*